Major gauges made slight losses as Wall Street prepares for a week of major releases against a backdrop of global volatility.

The company is highly popular among investors thanks to its solid position as a supplier of hardware that underpins AI ...

The S&P 500 rallied to a record high close on Friday, lifted by Broadcom and other chipmakers, while a weaker-than-expected ...

"Healthy economic and revenue growth, continued profit strength among the largest US stocks, and an emerging productivity ...

Worrying about the state of the home construction industry in the U.S. was reasonable, but the company didn't deserve the big ...

Oklo is designing and developing small nuclear reactors. After a strong run in 2025, the company's stock looks expensive.

The clinical-stage biotech could see its shares plummet should there be any clinical setback.

With earnings season about to kick off, U.S. stock futures slipped Sunday, after the Dow and S&P 500 closed Friday at record ...

Novo Nordisk faces slowing growth, competition, regulatory risks, and Wegovy pricing pressure, with DCF showing fair ...

Baird analyst Ben Kallo cut his rating on GE Vernova stock to Hold from Buy. He slashed his price target by $167 to $649 a ...

Rocket Lab won an $816M SDA contract, with space systems driving growth, validated tech, and a 79x EV/sales valuation. Read ...

Could the second year of President Trump's term buck theories suggesting seasonal headwinds heading into 2026?